openPR Logo
Press release

Acquired (Autoimmune) Hemolytic Anemia Market Significant Profits Estimated to be Generated by 2025

05-16-2018 03:48 PM CET | Health & Medicine

Press release from: Persistence Market Research

Acquired (Autoimmune) Hemolytic Anemia Market Significant

Hemolytic anemia is a diseased condition characterized by premature destruction of red blood cells (RBCs) and their removal from the blood circulatory system before their life span is over. Red blood cells also known as erythrocytes are disk like structures that carry oxygen from lungs to body organs and help in removing carbon dioxide from the body. Usually red blood cells (RBCs) have a normal life span of 120 before they are removed from the blood stream by spleen. Red blood cells are produced by bone marrow. In people suffering from acquired (autoimmune) hemolytic anemia, bone marrows are unable to produce enough RBCs to meet body’s demand.

Request Report for Table of Contents @ https://www.persistencemarketresearch.com/toc/19732

Acquired (autoimmune) hemolytic anemia is non-genetic in nature and usually occurs when the body’s own immune system destroys its healthy tissues against invading organisms such as lymphocytes and antibodies. Acquired (autoimmune) hemolytic anemia generally occurs as a result or in conjunction with some other medical conditions. This condition rarely occurs alone. Acquired (autoimmune) hemolytic anemia can be classified as warm antibody hemolytic anemia and cold antibody hemolytic anemia. In warm antibody hemolytic anemia, auto-antibodies attach with the red blood cells and kill them at temperature higher than the body temperature; conversely, in cold antibody hemolytic anemia self-generated antibodies kill red blood cells at a temperature below the body temperature.

Diagnosis involves a range of blood tests such as hemoglobin and hematocrit test, bilirubin test, serum haptoglobin test and reticulocyte count. If the ratio is high, there is likeliness of hemolytic anemia.  Coombs test is another key diagnostic method for acquired (autoimmune) hemolytic anemia in which the amount of certain antibodies is determined in order to check if it is higher than normal. Treatment is based on three major aims, preventing the destruction of RBCs, increasing the RBCs count and treating the origin of illness. Blood transfusion, medications, plasmapheresis and surgeries are among major treatment options. Prednisone, rituximab, hydroxyurea and cyclosporine are some drugs that are usually prescribed for treating acquired (autoimmune) hemolytic anemia.

There are no exact incidence and prevalence statistics are available regarding the acquired (autoimmune) hemolytic anemia. According to sources from Elsevier, Inc. the incidence rate of all types of acquired (autoimmune) hemolytic anemias range from one new case per 100,000 general population to 300,000 per year. Though the prevalence is not so high, severity of the condition will play a key role in driving the market growth. The market will also be driven by unmet medical needs as there is no standard medicines available for treating acquired hemolytic anemia. Many companies are conducting clinical trials in order to introduce effective medicines for acquired hemolytic anemia. Some major pharmaceutical companies and research institutions that are engaged in the development, manufacturing and marketing of drugs for this market include Novartis AG, Sanofi, Centre Hospitalier Universitaire Dijon, Institute of Hematology & Blood Diseases Hospital, Hoffmann-La Roche, National Cancer Institute (NCI), Agios Pharmaceuticals, Inc., Octapharma Pharmazeutika Produktionsges.m.b.H., National Heart, Lung, and Blood Institute (NHLBI) and Baxter Healthcare Corporation.

For More Information Request a Brochure of the Report @ https://www.persistencemarketresearch.com/samples/19732

Geographically, the acquired (autoimmune) hemolytic anemia market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). Globally, the market is led by North America, followed by Europe, Asia-Pacific and Rest of the World (RoW). High level of awareness, high per capita income and well established reimbursement scenario are among the major factors responsible for North America’s leading position in the acquired (autoimmune) hemolytic anemia market.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acquired (Autoimmune) Hemolytic Anemia Market Significant Profits Estimated to be Generated by 2025 here

News-ID: 1052012 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Acquired

Nao Group is Acquired by Dragon Gate
An ambitious property development firm has been acquired by an esteemed international investment group. In a move that paves the way towards further UK expansion, Nao Group has inked a deal with an Asian backed investment group, Dragon Gate. Following on from what has been a very tough year for the sector, this deal will provide Nao Group with the opportunity to acquire properties in high growth areas across the
Global Hospital-Acquired Infection Control Market Report
The findings reviewed by GME stated that the Hospital Acquired Infection Control Market will expand at a CAGR value of xx% to reach USD xx Million by 2026. Disinfection is the process of eliminating all forms of pathogens. The procedure is accomplished by the use of liquid chemicals. The advancement of technology in the medical industry has accelerated the evolution of the market and is expected to boost market
SOS acquired by PracticeEvolve
Solicitors Own Software (SOS) have announced the sale of the business to PracticeEvolve Group to continue to provide the market with progressive technology, supported by strong service and support. Operating since 1987, SOS have delivered practice and case management software and services to law firms across the UK. With over 17,000 users and a solid client base, Graham Colbourne, Managing Director, says the sale will ensure the market is provided
Recruitive Software acquired by SaaS Holdings Limited
SaaS Holdings Limited has confirmed today that it has completed the acquisition of the business and assets of Recruitive Software. The deal has taken in excess of twelve weeks to conclude whilst administrators sought a new buyer for the Intellectual property rights and assets of the software house. It is understood there were three or more interested parties competing for the business. The deal safeguards the jobs of the 33 staff
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets. Report Consultant has introduced a new report titled as Global Pneumonia
CAROLINA UNDERGROUND SOLUTIONS ACQUIRED
Entrepreneur and Greenville Businessman, Braddock Cunningham, Acquires Carolina Underground Solutions Greenville, SC (May 30, 2017) – [CAROLINA UNDERGROUND SOLUTIONS] CUS, a leading underground telecommunications cabling and conduit contractor, today announced that they have been acquired by Braddock Cunningham, former CEO of Network Controls and Electric, where he grew his company to a South Carolina top 25 fastest growing company 4 times between 2008 and 2013. Cunningham who holds a